Due to manufacturing problems with some generic products, the MHLW will now bolster GMP via issuing a new inspection manual. This inspection manual will apply to both generic and new drugs. Representatives from various pharmaceutical associations, the PMDA, and others have now set up a task force to study and write up a new inspection manual. The manual will not be a simple checklist but rather an extensive document outlining why inspections are required and priority items to be checked. The manual can be used by representatives of drug facilities to be inspected and inspectors. Hopefully, the inspection manual will make the public feel better after several drug scandals. It is expected to be issued and implemented by March 2023.